S T A T E O F N E W Y O R K
________________________________________________________________________
5317
2025-2026 Regular Sessions
I N S E N A T E
February 20, 2025
___________
Introduced by Sen. BAILEY -- read twice and ordered printed, and when
printed to be committed to the Committee on Crime Victims, Crime and
Correction
AN ACT to amend the correction law and the mental hygiene law, in
relation to data collected for medication assisted treatment programs
at correctional facilities
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. Subdivision 3 of section 626 of the correction law, as
separately amended by chapters 147 and 486 of the laws of 2022, is
amended to read as follows:
3. The commissioner shall [submit within one year of the effective
date of this section and annually thereafter, a report to the governor,
the temporary president of the senate and the speaker of the assembly on
the effectiveness of the program established pursuant to this section.
Such reports shall include an analysis of the impact of such program on
the participating incarcerated individuals, including factors such as
institutional adjustment, behavior infractions, reentry rates, HIV and
hepatitis C treatment, and program participation, among related relevant
factors. The reports shall also include the impact on institutional
safety and performance and any recommendations for additional legisla-
tive enactments that may be needed or required to improve or enhance the
program as determined to be appropriate by the commissioner], ALONG WITH
THE STATE COMMISSION OF CORRECTION, PROVIDE DATA NECESSARY TO COMPLETE
THE REPORT REQUIRED BY SUBDIVISION (H) OF SECTION 19.07 OF THE MENTAL
HYGIENE LAW TO THE COMMISSIONER OF THE OFFICE OF ADDICTION SERVICES AND
SUPPORTS.
§ 2. Subdivision (h) of section 19.07 of the mental hygiene law, as
separately amended by chapters 322 and 494 of the laws of 2021, is
amended to read as follows:
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD02571-01-5
S. 5317 2
(h) The office of addiction services and supports shall monitor
programs providing care and treatment to incarcerated individuals WHO
HAVE A HISTORY OF ALCOHOL OR SUBSTANCE USE DISORDER OR DEPENDENCE in
correctional facilities operated by the department of corrections and
community supervision [who have a history of alcohol or substance use
disorder or dependence] AND LOCAL COUNTIES. The office shall also
develop guidelines for the operation of alcohol and substance use disor-
der treatment programs in such correctional facilities, based on best
practices, and tailored to the nature of the individual's substance use,
history of past treatment, and history of mental illness or trauma,
which may include harm reduction strategies, in order to ensure that
such programs sufficiently meet the needs of incarcerated individuals
with a history of alcohol or substance use disorder or dependence and
promote the successful transition to treatment in the community upon
release. No later than the first day of December of each year, the
office IN COLLABORATION WITH THE DEPARTMENT OF CORRECTIONS AND COMMUNITY
SUPERVISION AND THE STATE COMMISSION OF CORRECTION shall submit a report
regarding: (1) the adequacy and effectiveness of alcohol and substance
use disorder treatment programs operated by the department of
corrections and community supervision AND LOCAL COUNTIES, INCLUDING
MEDICATION ASSISTED TREATMENT PROGRAMS AS ESTABLISHED BY SECTION 19.18-C
OF THIS ARTICLE AND SECTION SIX HUNDRED TWENTY-SIX OF THE CORRECTION
LAW; (2) the total number of incarcerated individuals AND THE DEMOGRAPH-
IC INFORMATION OF SUCH INCARCERATED INDIVIDUALS INCLUDING RACE, ETHNICI-
TY, GENDER AND AGE in EACH correctional [facilities that have been
screened for, and determined to have, a substance use disorder]
FACILITY; (3) information regarding which substances incarcerated indi-
viduals are most OFTEN dependent upon and the available treatment for
such individuals within each correctional facility; (4) the total number
of individuals who participate in each of the treatment programs oper-
ated by the department of corrections and community supervision AND
LOCAL COUNTIES; [and] (5) the total number of individuals who partic-
ipated in a substance use disorder treatment program but failed to
complete such program, as well as whether such failure to complete the
program was a result of disciplinary action taken by the facility
against the individual for instances unrelated to their participation in
the treatment program; AND (6) INFORMATION REGARDING MEDICATION ASSISTED
TREATMENT PROGRAMS OPERATED BY THE DEPARTMENT OF CORRECTIONS AND COMMU-
NITY SUPERVISION AND LOCAL COUNTIES, FOR WHICH ALL INDICES SHALL BE
BROKEN DOWN BY RACE, ETHNICITY, GENDER AND AGE, AND WHICH SHALL INCLUDE
THE FOLLOWING:
(I) THE NUMBER OF INDIVIDUALS SCREENED AT EACH FACILITY AND AT WHAT
POINT DURING SUCH INDIVIDUAL'S INCARCERATION THEY WERE SCREENED AND HOW
MANY HAD AN EXISTING PRESCRIPTION FOR A MEDICATION TO TREAT SUBSTANCE
USE DISORDER BEFORE BECOMING INCARCERATED;
(II) THE NUMBER OF INDIVIDUALS DETERMINED TO HAVE A SUBSTANCE USE
DISORDER THAT CAN BE TREATED WITH ONE OF THE FEDERAL FOOD AND DRUG
ADMINISTRATION (FDA) APPROVED MEDICATIONS AVAILABLE;
(III) THE NUMBER OF INDIVIDUALS OFFERED SUCH MEDICATION;
(IV) THE NUMBER OF INDIVIDUALS WHO ACCEPTED OR DECLINED SUCH MEDICA-
TION AND THE REASON FOR REJECTION IF AVAILABLE;
(V) THE MEDICATION TYPES USED, FOR HOW MANY PEOPLE, INCLUDING THE
AVERAGE DOSAGE AMOUNT FOR EACH FORM OF MEDICATION FOR SUBSTANCE USE
DISORDER USED;
S. 5317 3
(VI) WHETHER AND AT WHAT POINT DOSAGES CHANGED, INCLUDING FOR PEOPLE
WITH EXISTING PRESCRIPTIONS FOR A MEDICATION TO TREAT SUBSTANCE USE
DISORDER;
(VII) THE REGULATORY STRUCTURE USED TO PROVIDE METHADONE TO EACH
PATIENT INCLUDING: THE NAME OF ANY COMMUNITY-BASED OPIOID TREATMENT
PROGRAMS EACH FACILITY IS UTILIZING TO OBTAIN METHADONE AND THE DISTANCE
FROM THE FACILITY, WHETHER THE FACILITY IS OPERATING AS A MEDICATION
UNIT OF THE OPIOID TREATMENT PROGRAM, AND/OR WHETHER THE FACILITY IS
PROVIDING METHADONE DIRECTLY BY REGISTERING WITH THE FEDERAL DRUG
ENFORCEMENT AGENCY AS A HOSPITAL AND/OR CLINIC;
(VIII) THE NUMBER AND TYPES OF MEDICAL PROVIDERS ON STAFF TO PRESCRIBE
BUPRENORPHINE OR NALTREXONE AND THE NUMBER AND TYPES OF STAFF NEEDED TO
ADMINISTER SUCH MEDICATIONS;
(IX) THE TYPES AND DOSAGES OF OPIOID OVERDOSE REVERSAL MEDICATIONS
STOCKED AT EACH FACILITY AND THE NUMBER OF TIMES IT WAS USED INCLUDING
DATA ABOUT USAGE PRIOR TO IMPLEMENTATION OF THE MEDICATION ASSISTED
TREATMENT PROGRAM;
(X) THE RATES OF OVERDOSE BY INCARCERATED INDIVIDUALS PRESCRIBED MEDI-
CATIONS FOR OPIOID USE DISORDER INCLUDING WHICH MEDICATION WAS USED FOR
TREATMENT AND THE OVERALL RATES OF OVERDOSE IN EACH FACILITY BEFORE AND
AFTER IMPLEMENTATION OF THE MEDICATION ASSISTED TREATMENT PROGRAM;
(XI) THE RATES OF OTHER HEALTH ISSUES ASSOCIATED WITH SUBSTANCE USE
DISORDER INCLUDING HIV, HEPATITIS C, AND MENTAL HEALTH DIAGNOSES;
(XII) AN ANALYSIS OF THE IMPACT OF SUCH ALCOHOL AND SUBSTANCE USE
DISORDER TREATMENT PROGRAMS ON PARTICIPATING INCARCERATED INDIVIDUALS,
INCLUDING INSTITUTIONAL ADJUSTMENT, BEHAVIOR INFRACTIONS, AND RE-ENTRY
RATES, AMONG OTHER RELEVANT FACTORS. SUCH ANALYSIS SHALL ALSO INCLUDE
THE IMPACT ON INSTITUTIONAL SAFETY AND PERFORMANCE AND ANY RECOMMENDA-
TIONS FOR ADDITIONAL LEGISLATIVE ACTIONS THAT MAY BE NEEDED OR REQUIRED
TO IMPROVE OR ENHANCE THE PROGRAM AS DETERMINED TO BE APPROPRIATE BY THE
COMMISSIONER; AND
(XIII) THE NUMBER OF INCIDENTS INVOLVING ILLICIT SUBSTANCES IN THE
FACILITY BEFORE AND AFTER THE INITIATION OF MEDICATIONS FOR SUBSTANCE
USE DISORDER. The department of corrections and community supervision
AND LOCAL COUNTIES shall provide the office with information needed to
complete this report. Such report shall be MADE AVAILABLE TO THE PUBLIC
ON THE OFFICE'S WEBSITE AND sent to the governor, the temporary presi-
dent of the senate, the speaker of the assembly, the [chairman] CHAIR-
PERSON of the senate committee on crime victims, crime and correction,
and the [chairman] CHAIRPERSON of the assembly committee on correction.
§ 3. This act shall take effect immediately.